Egyptian Society of Cardiology

The Egyptian Working Group for Cardiovascular Drug Therapy

The working group whose primary interest is to promote and advance the science of human pharmacology and therapeutics in the field of Cardiology.

As a learned working group, our primary concerns are better understanding and use of existing drug therapies, and developing better and safer treatments for the future.

Our memberships' unique combination of scientific and clinical expertise makes them especially qualified to understand the impact of disease on patients, the compelling need for effective drug therapy and the efforts necessary to meet those needs.

Such efforts include research, exchange of scientific information, consideration of legislation and regulations that affect drug development and utilization, and education.

Scientific Presentations in meetings should relate to mechanisms of action, drug metabolism, drug safety and efficacy, pharmacodynamics, pharmacokinetics, study methodology, education, and other aspects of clinical pharmacology.

MISSION

The working group for Clinical Pharmacology and Therapeutics advances the discipline and practice of clinical pharmacology for the benefit of patients and the working group.

VISION

The working group fosters the recognition of clinical pharmacology as a discipline at the forefront of the discovery, development, regulation and use of safe and effective medicines.

CORE PRINCIPLES

Our uniqueness lies in our service and expertise along the continuum of clinical pharmacology that is necessary for the discovery, development, regulation and utilization of safe and effective drugs.

We strive to be leaders in basic, translational and clinical pharmacological research because we believe that the quality and integrity of such research is essential.

We strive to ensure that cardiologists value clinical pharmacology as a focused, integrated and essential discipline for quality patient care.

We believe cardiologists must be trained in the principles and practices of clinical pharmacology in order to provide safe and effective therapeutics and quality patient care.

We support diversity and the exchange of scientific information within the discipline of cardiology and clinical pharmacology and among related disciplines, recognizing the complementary and unique contributions made by the different healthcare professions within medical science.

Make Voice Heard As the working group advocates on your behalf regarding important practice and research issues through use of the online Legislative Action Center Through sharing your concerns and opinions with an organization that values the input of its members The working group exists to advance human health and quality of life by helping cardiologists to expand the frontiers of their practice and research. The working group will pursue its core purpose by:

• Providing leadership, education, advocacy, and other resources that enable pharmacists to achieve excellence in clinical practice and  research:
• advancing pharmacotherapy through support and promotion of research, training, and educational programs; and
• disseminating peer-reviewed, innovative scientific and professional information and knowledge that catalyze change and advance drug therapy.